Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing
Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252